Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Diabetes Reports
Erschienen in: Current Diabetes Reports 7/2017

01.07.2017 | Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes

verfasst von: Sherita Hill Golden, Nisa Maruthur, Nestoras Mathioudakis, Elias Spanakis, Daniel Rubin, Mihail Zilbermint, Felicia Hill-Briggs

Erschienen in: Current Diabetes Reports | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The goal of this review is to describe diabetes within a population health improvement framework and to review the evidence for a diabetes population health continuum of intervention approaches, including diabetes prevention and chronic and acute diabetes management, to improve clinical and economic outcomes.

Recent Findings

Recent studies have shown that compared to usual care, lifestyle interventions in prediabetes lower diabetes risk at the population-level and that group-based programs have low incremental medial cost effectiveness ratio for health systems. Effective outpatient interventions that improve diabetes control and process outcomes are multi-level, targeting the patient, provider, and healthcare system simultaneously and integrate community health workers as a liaison between the patient and community-based healthcare resources. A multi-faceted approach to diabetes management is also effective in the inpatient setting. Interventions shown to promote safe and effective glycemic control and use of evidence-based glucose management practices include provider reminder and clinical decision support systems, automated computer order entry, provider education, and organizational change.

Summary

Future studies should examine the cost-effectiveness of multi-faceted outpatient and inpatient diabetes management programs to determine the best financial models for incorporating them into diabetes population health strategies.
Literatur
1.
• Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):1021–9. This article contains the most up-to-date diabetes prevalence estimates for the United States. PubMedCrossRef
2.
Courtney-Long EA, Carroll DD, Zhang QC, Stevens AC, Griffin-Blake S, Armour BS, et al. Prevalence of disability and disability type among adults—United States, 2013. Mmwr-Morbid Mortal W. 2015;64(29):777–83.CrossRef
3.
Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: final data for 2014. National Center for Health Statistics, Division of Vital Statistics. 2016;65(4):1–122.
4.
Dieleman JL, Baral R, Birger M, Bui AL, Bulchis A, Chapin A, et al. US spending on personal health care and public health, 1996-2013. JAMA. 2016;316(24):2627–46.PubMedCrossRef
5.
Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors—an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012;97(9):E1579–639.PubMedPubMedCentralCrossRef
6.
National Center for Health Statistics. Health, United States, 2015: with special feature on racial and ethnic health disparities, Hyattsville, MD, 2016.
7.
8.
Stiefel M, Nolan K. A guide to measuring the triple aim: population health, experience of care, and per capital costs. Cambridge: Institute for Healthcare Improvement; 2012.
9.
Dunn JR, Hayes MV. Toward a lexicon of population health. Canadian Journal of Public Health-Revue Canadienne De Sante Publique. 1999;90:S7–S10.PubMed
10.
Mathioudakis N, Golden SH. A comparison of inpatient glucose management guidelines: implications for patient safety and quality. Current Diabetes Reports. 2015;15(3):13.PubMedPubMedCentralCrossRef
11.
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353–69.PubMedCrossRef
12.
American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef
13.
Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.PubMedCrossRef
14.
Maynard G, Schnipper JL, Messler J, Ramos P, Kulasa K, Nolan A, et al. Design and implementation of a web-based reporting and benchmarking center for inpatient glucometrics. Journal of diabetes science and technology. 2014;8(4):630–40.PubMedPubMedCentralCrossRef
15.
Thomas P, Inzucchi SE. An internet service supporting quality assessment of inpatient glycemic control. Journal of diabetes science and technology. 2008;2(3):402–8.PubMedPubMedCentralCrossRef
16.
17.
American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40:S11–24.CrossRef
18.
19.
Centers for Disease Control and Prevention. Awareness of prediabetes—United States, 2005-2010. MMWR Morb Mortal Wkly Rep. 2013;62(11):209–12.
20.
Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract. 2005;67(2):152–62.PubMedCrossRef
21.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEngl J Med. 2002;346(6):393–403.CrossRef
22.
Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86. doi:10.​1016/​S0140-6736(09)61457-4.PubMedCentralCrossRef
23.
•• Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. The lancet Diabetes & endocrinology. 2015;3(11):866–75. This article summarizes the long-term effects of the Diabetes Prevention Program interventions on the risk of microvascular complications of diabetes. CrossRef
24.
Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243–51.PubMedPubMedCentralCrossRef
25.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.PubMedCrossRef
26.
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–97.PubMedCrossRef
27.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.PubMedCrossRef
28.
Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371(9626):1783–9.PubMedCrossRef
29.
Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. The lancet Diabetes & endocrinology. 2014;2(6):474–80.CrossRef
30.
Ackermann RT, Finch EA, Caffrey HM, Lipscomb ER, Hays LM, Saha C. Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study. Chronic illness. 2011;7(4):279–90.PubMedCrossRef
31.
Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163(6):437–51.PubMedPubMedCentralCrossRef
32.
Diabetes Prevention Program Research G. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012;35(4):723–30.CrossRef
33.
Li R, Qu S, Zhang P, Chattopadhyay S, Gregg EW, Albright A, et al. Economic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163(6):452–60.PubMedPubMedCentralCrossRef
34.
Cefalu WT, Buse JB, Tuomilehto J, Fleming GA, Ferrannini E, Gerstein HC, et al. Update and next steps for real-world translation of interventions for type 2 diabetes prevention: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2016;39(7):1186–201.PubMedCrossRef
35.
Saaristo T, Moilanen L, Korpi-Hyovalti E, Vanhala M, Saltevo J, Niskanen L, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care. 2010;33(10):2146–51.PubMedPubMedCentralCrossRef
36.
Schwarz PE, Lindstrom J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M, et al. The European perspective of type 2 diabetes prevention: diabetes in Europe—prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association. 2008;116(3):167–72.CrossRef
37.
38.
39.
40.
Office of the Actuary. Certification of Medicare diabetes prevention program. Baltimore: Centers for Medicare and Medicaid Services; 2016.
41.
• Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Hess Fischl A, et al. Diabetes self-management education and support in type 2 diabetes: a Joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Care. 2015;38(7):1372–82. This article provides current state of the art recommendations for diabetes self-management education and support for patients with type 2 diabetes. PubMedCrossRef
42.
American Diabetes Association. Lifestyle management. Diabetes Care. 2017;40(Suppl. 1):S33–43.CrossRef
43.
Duke SA, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. The Cochrane database of systematic reviews. 2009;1:CD005268.
44.
Steinsbekk A, Rygg LO, Lisulo M, Rise MB, Fretheim A. Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv Res. 2012;12:213.PubMedPubMedCentralCrossRef
45.
Sigurdardottir AK, Jonsdottir H, Benediktsson R. Outcomes of educational interventions in type 2 diabetes: WEKA data-mining analysis. Patient Educ Couns. 2007;67(1–2):21–31.PubMedCrossRef
46.
Attridge M, Creamer J, Ramsden M, Cannings-John R, Hawthorne K. Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus. The Cochrane database of systematic reviews. 2014;9:CD006424.
47.
Joseph JJ, Golden SH. Diabetes in native populations and underserved communities in the USA. In: Dagogo-Jack S, editor. Diabetes mellitus in developing and underserved communities. Switzerland: Springer International Publishing; 2017. p. 251–84.CrossRef
48.
Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379(9833):2252–61.PubMedCrossRef
49.
Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA. 2006;296(4):427–40.PubMedCrossRef
50.
Pimouguet C, Le Goff M, Thiebaut R, Dartigues JF, Helmer C. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2011;183(2):E115–27.PubMedCrossRef
51.
Glazier RH, Bajcar J, Kennie NR, Willson K. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care. 2006;29(7):1675–88.PubMedCrossRef
52.
Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007;64(5):101S–56S.PubMedPubMedCentralCrossRef
53.
Ricci-Cabello I, Ruiz-Perez I, Olry dL, Marquez-Calderon S. Do social inequalities exist in terms of the prevention, diagnosis, treatment, control and monitoring of diabetes? A systematic review. Health Soc Care Community. 2010;18(6):572–87.PubMedCrossRef
54.
Shah M, Kaselitz E, Heisler M. The role of community health workers in diabetes: update on current literature. Current diabetes reports. 2013;13(2):163–71.PubMedPubMedCentralCrossRef
55.
Hunt CW, Grant JS, Appel SJ. An integrative review of community health advisors in type 2 diabetes. J Community Health. 2011;36(5):883–93.PubMedCrossRef
56.
Norris SL, Chowdhury FM, Van Le K, Horsley T, Brownstein JN, Zhang X, et al. Effectiveness of community health workers in the care of persons with diabetes. Diabetic medicine: a journal of the British Diabetic Association. 2006;23(5):544–56.CrossRef
57.
Gary TL, Batts-Turner M, Yeh HC, Hill-Briggs F, Bone LR, Wang NY, et al. The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med. 2009;169(19):1788–94.PubMedCrossRef
58.
Kane EP, Collinsworth AW, Schmidt KL, Brown RM, Snead CA, Barnes SA, et al. Improving diabetes care and outcomes with community health workers. Fam Pract. 2016;33(5):523–8.PubMedCrossRef
59.
Fox CH, Mahoney MC. Improving diabetes preventive care in a family practice residency program: a case study in continuous quality improvement. Fam Med. 1998;30(6):441–5.PubMed
60.
Phillips LS, Hertzberg VS, Cook CB, El-Kebbi IM, Gallina DL, Ziemer DC, et al. The Improving Primary Care of African Americans with Diabetes (IPCAAD) project: rationale and design. Control Clin Trials. 2002;23(5):554–69.PubMedCrossRef
61.
Phillips LS, Ziemer DC, Doyle JP, Barnes CS, Kolm P, Branch WT, et al. An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care. 2005;28(10):2352–60.PubMedCrossRef
62.
Ziemer DC, Tsui C, Caudle J, Barnes CS, Dames F, Phillips LS. An informatics-supported intervention improves diabetes control in a primary care setting. AMIA annual symposium proceedings/amia symposium amia symposium. 2006:1160.
63.
Ricci-Cabello I, Ruiz-Perez I, Nevot-Cordero A, Rodriguez-Barranco M, Sordo L, Goncalves DC. Health care interventions to improve the quality of diabetes care in African Americans: a systematic review and meta-analysis. Diabetes Care. 2013;36(3):760–8.PubMedPubMedCentralCrossRef
64.
Thaler LM, Ziemer DC, Gallina DL, Cook CB, Dunbar VG, Phillips LS, et al. Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care. 1999;22(9):1415–21.PubMedCrossRef
65.
Cook CB, Penman A, Cobb AB, Miller D, Murphy T, Horn T. Outpatient diabetes management of Medicare beneficiaries in four Mississippi fee-for-service primary care clinics. J Miss State Med Assoc. 1999;40(1):8–13.PubMed
66.
Bray P, Thompson D, Wynn JD, Cummings DM, Whetstone L. Confronting disparities in diabetes care: the clinical effectiveness of redesigning care management for minority patients in rural primary care practices. The Journal of rural health: official journal of the American Rural Health Association and the National Rural Health Care Association. 2005;21(4):317–21.CrossRef
67.
Anderson-Loftin W, Barnett S, Sullivan P, Bunn PS, Tavakoli A. Culturally competent dietary education for southern rural African Americans with diabetes. The Diabetes educator. 2002;28(2):245–57.PubMedCrossRef
68.
Mahotiere T, Ocepek-Welikson K, Daley MB, Byssainthe JP. A program to reduce the disparity in the rate of biennial lipid profiles between African-American and white Medicare beneficiaries with diabetes mellitus in New York City. J Community Health. 2006;31(4):263–88.PubMedCrossRef
69.
Rith-Najarian S, Branchaud C, Beaulieu O, Gohdes D, Simonson G, Mazze R. Reducing lower-extremity amputations due to diabetes—application of the staged diabetes management approach in a primary care setting. J Fam Pract. 1998;47(2):127–32.PubMed
70.
Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33(8):1872–94.PubMedPubMedCentralCrossRef
71.
Richard P, Shin P, Beeson T, Burke LS, Wood SF, Rosenbaum S. Quality and cost of diabetes mellitus care in Community Health Centers in the United States. PLoS One. 2015;10(12):e0144075.PubMedPubMedCentralCrossRef
72.
Huang ES, Brown SE, Zhang JX, Kirchhoff AC, Schaefer CT, Casalino LP, et al. The cost consequences of improving diabetes care: the community health center experience. Joint Commission journal on quality and patient safety/Joint Commission Resources. 2008;34(3):138–46.PubMedCentralCrossRef
73.
Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775–9.PubMedCrossRef
74.
Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001;285(2):182–9.PubMedCrossRef
75.
Ansell D, Schiff R, Goldberg D, Furumoto-Dawson A, Dick S, Peterson C. Primary care access decreases nonurgent hospital visits for indigent diabetics. J Health Care Poor Underserved. 2002;13(2):171–83.PubMedCrossRef
76.
Sadur CN, Moline N, Costa M, Michalik D, Mendlowitz D, Roller S, et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care. 1999;22(12):2011–7.PubMedCrossRef
77.
Nason GJ, Strapp H, Kiernan C, Moore K, Gibney J, Feeley TM, et al. The cost utility of a multi-disciplinary foot protection clinic (MDFPC) in an Irish hospital setting. Ir J Med Sci. 2013;182(1):41–5.PubMedCrossRef
78.
Schouten LM, Niessen LW, van de Pas JW, Grol RP, Hulscher ME. Cost-effectiveness of a quality improvement collaborative focusing on patients with diabetes. Med Care. 2010;48(10):884–91.PubMedCrossRef
79.
Wagner EH, Grothaus LC, Sandhu N, Galvin MS, McGregor M, Artz K, et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care. 2001;24(4):695–700.PubMedCrossRef
80.
de Weerdt I, Visser AP, Kok GJ, de Weerdt O, van der Veen EA. Randomized controlled multicentre evaluation of an education programme for insulin-treated diabetic patients: effects on metabolic control, quality of life, and costs of therapy. Diabet Med. 1991;8(4):338–45.PubMedCrossRef
81.
Dougherty G, Schiffrin A, White D, Soderstrom L, Sufrategui M. Home-based management can achieve intensification cost-effectively in type I diabetes. Pediatrics. 1999;103(1):122–8.PubMedCrossRef
82.
83.
84.
Centers for Disease C, Prevention. Increasing prevalence of diagnosed diabetes—United States and Puerto Rico, 1995-2010. MMWR Morb Mortal Wkly Rep. 2012;61(45):918–21.
85.
Jones AP, Homer JB, Murphy DL, Essien JD, Milstein B, Seville DA. Understanding diabetes population dynamics through simulation modeling and experimentation. Am J Public Health. 2006;96(3):488–94.PubMedPubMedCentralCrossRef
86.
87.
American Diabetes Association. Economic costs of diabetes in the U.S. Diabetes Care. 2008;31(3):1–20.CrossRef
88.
Kim S. Burden of hospitalizations primarily due to uncontrolled diabetes: implications of inadequate primary health care in the United States. Diabetes Care. 2007;30(5):1281–2.PubMedCrossRef
89.
Curkendall SM, Natoli JL, Alexander CM, Nathanson BH, Haidar T, Dubois RW. Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract. 2009;15(4):302–12.PubMedCrossRef
90.
ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006;12(Suppl 3):4–13.
91.
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.PubMedPubMedCentralCrossRef
92.
93.
Munoz C, Lowry C, Smith C. Continuous quality improvement: hypoglycemia prevention in the postoperative surgical population. Medsurg Nurs. 2012;21(5):275–80.PubMed
94.
Trujillo JM, Barsky EE, Greenwood BC, Wahlstrom SA, Shaykevich S, Pendergrass ML, et al. Improving glycemic control in medical inpatients: a pilot study. J Hosp Med. 2008;3(1):55–63.PubMedCrossRef
95.
Herring R, Pengilley C, Hopkins H, Tuthill B, Patel N, Nelson C, et al. Can an interprofessional education tool improve healthcare professional confidence, knowledge and quality of inpatient diabetes care: a pilot study? Diabet Med. 2013;30(7):864–70.PubMedCrossRef
96.
Donaldson S, Villanuueva G, Rondinelli L, Baldwin D. Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients: elimination of the sliding scale and improvement of glycemic control throughout the hospital. The Diabetes educator. 2006;32(6):954–62.PubMedCrossRef
97.
Lee J, Clay B, Zelazny Z, Maynard G. Indication-based ordering: a new paradigm for glycemic control in hospitalized inpatients. Journal of diabetes science and technology. 2008;2(3):349–56.PubMedPubMedCentralCrossRef
98.
Schnipper JL, Ndumele CD, Liang CL, Pendergrass ML. Effects of a subcutaneous insulin protocol, clinical education, and computerized order set on the quality of inpatient management of hyperglycemia: results of a clinical trial. J Hosp Med. 2009;4(1):16–27.PubMedCrossRef
99.
Flanders SJ, Juneja R, Roudebush CP, Carroll J, Golas A, Elias BL. Glycemic control and insulin safety: the impact of computerized intravenous insulin dosing. American journal of medical quality: the official journal of the American College of Medical Quality. 2009;24(6):489–97.CrossRef
100.
Gilman JA. A quality improvement project for better glycemic control in hospitalized patients with diabetes. The Diabetes educator. 2001;27(4):541–6.PubMedCrossRef
101.
Pasala S, Dendy JA, Chockalingam V, Meadows RY. An inpatient hypoglycemia committee: development, successful implementation, and impact on patient safety. Ochsner J. 2013;13(3):407–12.PubMedPubMedCentral
102.
Korytkowski M, Dinardo M, Donihi AC, Bigi L, Devita M. Evolution of a diabetes inpatient safety committee. Endocr Pract. 2006;12(Suppl 3):91–9.PubMedCrossRef
103.
Draznin B, Gilden J, Golden SH, Inzucchi SE, PRIDE investigators, Baldwin D, et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care. 2013;36(7):1807–14.PubMedPubMedCentralCrossRef
104.
Boffa DP, Pawola LM. Identification and conceptualization of nurse super users. J Healthc Inf Manag. 2006;20(4):60–8.PubMed
105.
McIntire S, Clark T. Essential steps in super user education for ambulatory clinic nurses. Urol Nurs. 2009;29(5):337–42. quiz 43 PubMed
106.
Selig PM, Popek V, Peebles KM. Minimizing hypoglycemia in the wake of a tight glycemic control protocol in hospitalized patients. J Nurs Care Qual. 2010;25(3):255–60.PubMedCrossRef
107.
Murphy DM, Vercruysse RA, Bertucci TM, Wall MJ, Schriever AE, Nabhan FA, et al. Reducing hyperglycemia hospitalwide: the basal-bolus concept. Joint Commission journal on quality and patient safety/Joint Commission Resources. 2009;35(4):216–23.CrossRef
108.
Kemmerer T, Bashura H, Dintzis J, Mathioudakis N, Golden SH. The impact of nursing and advanced practice clinician on the implementation and outcomes of an inpatient glucose management program. AADE In Practice. 2015:17–25.
109.
Golden SH, Hager D, Gould LJ, Mathioudakis N, Pronovost P. A gap analysis needs assessment tool to drive a care delivery and research agenda for integration of care and sharing of best practices across a health system. The Joint Commission Journal on Quality and Patient Safety. 2017;43:18–28.PubMedCrossRef
110.
Ena J, Casan R, Lozano T, Leach A, Algado JT, Navarro-Diaz FJ. Long-term improvements in insulin prescribing habits and glycaemic control in medical inpatients associated with the introduction of a standardized educational approach. Diabetes Res Clin Pract. 2009;85(2):159–65.PubMedCrossRef
111.
Donihi AC, Gibson JM, Noschese ML, DiNardo MM, Koerbel GL, Curll M, et al. Effect of a targeted glycemic management program on provider response to inpatient hyperglycemia. Endocr Pract. 2011;17(4):552–7.PubMedCrossRef
112.
Munoz M, Pronovost P, Dintzis J, Kemmerer T, Wang NY, Chang YT, et al. Implementing and evaluating a multicomponent inpatient diabetes management program: putting research into practice. Joint Commission journal on quality and patient safety/Joint Commission Resources. 2012;38(5):195–206.PubMedCentralCrossRef
113.
Nirantharakumar K, Chen YF, Marshall T, Webber J, Coleman JJ. Clinical decision support systems in the care of inpatients with diabetes in non-critical care setting: systematic review. Diabet Med. 2012;29(6):698–708.PubMedCrossRef
114.
115.
Neubauer KM, Mader JK, Höll B, Aberer F, Donsa K, Augustin T, et al. Standardized glycemic management with a computerized workflow and decision support system for hospitalized patients with type 2 diabetes on different wards. Diabetes Technol Ther. 2015;17(10):685–92.PubMedPubMedCentralCrossRef
116.
Gianchandani R, Umpierrez GE. Inpatient use of computer-guided insulin devices moving into the non-intensive care unit setting. Diabetes Technol Ther. 2015;17(10):673–5.PubMedPubMedCentralCrossRef
117.
• Aloi J, Bode BW, Ullal J, Chidester P, McFarland RS, Bedingfield AE, et al. Comparison of an electronic glycemic management system versus provider-managed subcutaneous basal bolus insulin therapy in the hospital setting. J Diabetes Sci Technol. 2016; doi:10.​1177/​1932296816664746​. This study showed that Electronic Glycemic Management System (eGMS) achieved glycemic control with less hypoglycemia compared to basal-bolus insulin managed by a prescriber.
118.
Thabit H, Hartnell S, Allen JM, Lake A, Wilinska ME, Ruan Y, et al. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. Lancet Diabetes Endocrinol. 2016; doi:10.​1016/​S2213-8587(16)30280-7.
119.
Wallia A, Umpierrez GE, Nasraway SA, Klonoff DC, Investigators P. Round table discussion on inpatient use of continuous glucose monitoring at the International Hospital Diabetes Meeting. J Diabetes Sci Technol. 2016;10(5):1174–81.PubMedPubMedCentralCrossRef
120.
Mendez CE, Ata A, Rourke JM, Stain SC, Umpierrez G. Daily inpatient glycemic survey (DINGS): a process to remotely identify and assist in the management of hospitalized patients with diabetes and hyperglycemia. Endocr Pract. 2015;21(8):927–35.PubMedCrossRef
121.
Boaz M, Landau Z, Matas Z, Wainstein J. Institutional blood glucose monitoring system for hospitalized patients: an integral component of the inpatient glucose control program. J Diabetes Sci Technol. 2009;3(5):1168–74.PubMedPubMedCentralCrossRef
122.
O’Neill AE, Miranda D. The right tools can help critical care nurses save more lives. Crit Care Nurs Q. 2006;29(4):275–81.PubMedCrossRef
123.
Thompson R, Schreuder AB, Wisse B, Jarman K, Givan K, Suhr L, et al. Improving insulin ordering safely: the development of an inpatient glycemic control program. J Hosp Med. 2009;4(7):E30–5.PubMedCrossRef
124.
Engle M, Ferguson A, Fields W. A journey to improved inpatient glycemic control by redesigning meal delivery and insulin administration. Clin Nurse Spec. 2016;30(2):117–24.PubMedCrossRef
125.
Lee SY, Askin G, McDonnell ME, Arnold LM, Alexanian SM. Hypoglycemia rates after restriction of high-dose glargine in hospitalized patients. Endocr Pract. 2016; doi:10.​4158/​EP161288.​OR.
126.
Arnold LM, Mahesri M, McDonnell ME, Alexanian SM. Glycemic outcomes three years after implementation of a perioperative glycemic control algorithm in an academic institution. Endocr Pract. 2016; doi:10.​4158/​EP161354.​OR.
127.
Tanner J, Padley W, Assadian O, Leaper D, Kiernan M, Edmiston C. Do surgical care bundles reduce the risk of surgical site infections in patients undergoing colorectal surgery? A systematic review and cohort meta-analysis of 8,515 patients. Surgery. 2015;158(1):66–77.PubMedCrossRef
128.
Levetan CS, Salas JR, Wilets IF, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995;99(1):22–8.PubMedCrossRef
129.
Koproski J, Pretto Z, Poretsky L. Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care. 1997;20(10):1553–5.PubMedCrossRef
130.
Simmons D, Hartnell S, Watts J, Ward C, Davenport K, Gunn E, et al. Effectiveness of a multidisciplinary team approach to the prevention of readmission for acute glycaemic events. Diabetic medicine: a journal of the British Diabetic Association. 2015;32(10):1361–7.CrossRef
131.
Feddersen E, Lockwood DH. An inpatient diabetes educator’s impact on length of hospital stay. The Diabetes educator. 1994;20(2):125–8.PubMedCrossRef
132.
Horton WB, Weeks AQ, Rhinewalt JM, Ballard RD, Asher FH. Analysis of a guideline-derived resident educational program on inpatient glycemic control. South Med J. 2015;108(10):596–8.PubMed
133.
Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;129(3):644–50.PubMedCrossRef
134.
Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2006;12(Suppl 3):43–8.CrossRef
135.
Rasekaba TM, Lim WK, Hutchinson AF. Effect of a chronic disease management service for patients with diabetes on hospitalisation and acute care costs. Australian health review: a publication of the Australian Hospital Association. 2012;36(2):205–12.CrossRef
136.
Crolla RM, van der Laan L, Veen EJ, Hendriks Y, van Schendel C, Kluytmans J. Reduction of surgical site infections after implementation of a bundle of care. PLoS One. 2012;7(9):e44599.PubMedPubMedCentralCrossRef
137.
Rubin DJ. Hospital readmission of patients with diabetes. Curr Diab Rep. 2015;15(4):1–9.CrossRef
138.
Davies M, Dixon S, Currie CJ, Davis RE, Peters JR. Evaluation of a hospital diabetes specialist nursing service: a randomized controlled trial. Diabet Med. 2001;18(4):301–7.PubMedCrossRef
139.
Healy SJ, Black D, Harris C, Lorenz A, Dungan KM. Inpatient diabetes education is associated with less frequent hospital readmission among patients with poor glycemic control. Diabetes Care. 2013;36(10):2960–7.PubMedPubMedCentralCrossRef
140.
Dungan K, Lyons S, Manu K, Kulkarni M, Ebrahim K, Grantier C, et al. An individualized inpatient diabetes education and hospital transition program for poorly controlled hospitalized patients with diabetes. Endocr Pract. 2014:1–24.
141.
Kampan P. Effects of counseling and implementation of clinical pathway on diabetic patients hospitalized with hypoglycemia. J Med Assoc Thail. 2006;89(5):619–25.
142.
143.
Wu EQ, Zhou S, Yu A, Lu M, Sharma H, Gill J, et al. Outcomes associated with post-discharge insulin continuity in US patients with type 2 diabetes mellitus initiating insulin in the hospital. Hosp Pract (1995). 2012;40(4):40–8.CrossRef
144.
Lee PH, Franks AS, Barlow PB, Farland MZ. Hospital readmission and emergency department use based on prescribing patterns in patients with severely uncontrolled type 2 diabetes mellitus. Diabetes Technol Ther. 2014;16(3):150–5.PubMedCrossRef
145.
Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and Medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995). 2014;42(1):46–51.CrossRef
146.
Maldonado MR, D’Amico S, Rodriguez L, Iyer D, Balasubramanyam A. Improved outcomes in indigent patients with ketosis-prone diabetes: effect of a dedicated diabetes treatment unit. Endocr Pract. 2003;9(1):26–32.PubMedCrossRef
147.
Rubin D, Donnell-Jackson K, Jhingan R, Golden SH, Paranjape A. Early readmission among patients with diabetes: a qualitative assessment of contributing factors. J Diabetes Complicat. 2014;28(6):869–73.PubMedCrossRef
148.
149.
150.
151.
•• Rubin DJ, Handorf EA, Golden SH, Nelson DB, McDonnell ME, Zhao H. Development and validation of a novel tool to predict hospital readmission risk among patients with diabetes. Endocr Pract. 2016;22(10):1204–15. This article presents a novel risk prediction tool to identify patients at risk for 30-day readmissions based on readily available clinical and sociodemographic data. PubMedPubMedCentralCrossRef
Metadaten
Titel
The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes
verfasst von
Sherita Hill Golden
Nisa Maruthur
Nestoras Mathioudakis
Elias Spanakis
Daniel Rubin
Mihail Zilbermint
Felicia Hill-Briggs
Publikationsdatum
01.07.2017
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 7/2017
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-017-0875-2

Weitere Artikel der Ausgabe 7/2017

Current Diabetes Reports 7/2017 Zur Ausgabe

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

Islet Microencapsulation: Strategies and Clinical Status in Diabetes

Psychosocial Aspects (S Jaser, Section Editor)

Assessing Psychological Insulin Resistance in Type 2 Diabetes: a Critical Comparison of Measures

Pediatric Type 2 and Monogenic Diabetes (PS Zeitler, Section Editor)

Adolescent’s Health Behaviors and Risk for Insulin Resistance: A Review of the Literature

Psychosocial Aspects (S Jaser, Section Editor)

Psychosocial Patient-Reported Outcomes in Pediatric and Adolescent Diabetes: a Review and Case Example

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

Combination Immunotherapy for Type 1 Diabetes

Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

Practical Recommendations for Transitioning Patients with Type 2 Diabetes from Hospital to Home

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise